20
Dipharma Francis Srl, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DAPSONE, with a corresponding US DMF Number 31521.
Remarkably, this DMF maintains an Active status since its submission on June 22, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 04, 2020, and payment made on October 30, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II